HK1009243A1 - Phosphate-binding polymers for oral administration - Google Patents

Phosphate-binding polymers for oral administration

Info

Publication number
HK1009243A1
HK1009243A1 HK98109833A HK98109833A HK1009243A1 HK 1009243 A1 HK1009243 A1 HK 1009243A1 HK 98109833 A HK98109833 A HK 98109833A HK 98109833 A HK98109833 A HK 98109833A HK 1009243 A1 HK1009243 A1 HK 1009243A1
Authority
HK
Hong Kong
Prior art keywords
phosphate
oral administration
binding polymers
polymers
binding
Prior art date
Application number
HK98109833A
Other languages
English (en)
Inventor
Stephen Randall Holmes-Farley
Mandeville W Harry Iii
George Mcclelland Whitesides
Original Assignee
Geltex Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26802726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1009243(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geltex Pharma Inc filed Critical Geltex Pharma Inc
Priority to HK01107241A priority Critical patent/HK1036753A1/xx
Publication of HK1009243A1 publication Critical patent/HK1009243A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Resins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Polyesters Or Polycarbonates (AREA)
HK98109833A 1993-08-11 1998-08-11 Phosphate-binding polymers for oral administration HK1009243A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK01107241A HK1036753A1 (en) 1993-08-11 1998-08-11 Polymer compositions for use in therapy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10559193A 1993-08-11 1993-08-11
US08/238,458 US5496545A (en) 1993-08-11 1994-05-05 Phosphate-binding polymers for oral administration
PCT/US1994/009060 WO1995005184A2 (en) 1993-08-11 1994-08-10 Phosphate-binding polymers for oral administration

Publications (1)

Publication Number Publication Date
HK1009243A1 true HK1009243A1 (en) 1999-05-28

Family

ID=26802726

Family Applications (2)

Application Number Title Priority Date Filing Date
HK01107241A HK1036753A1 (en) 1993-08-11 1998-08-11 Polymer compositions for use in therapy
HK98109833A HK1009243A1 (en) 1993-08-11 1998-08-11 Phosphate-binding polymers for oral administration

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK01107241A HK1036753A1 (en) 1993-08-11 1998-08-11 Polymer compositions for use in therapy

Country Status (16)

Country Link
US (1) US5496545A (es)
EP (3) EP0716606B1 (es)
JP (2) JP3113283B2 (es)
KR (1) KR100346766B1 (es)
AT (2) ATE204756T1 (es)
AU (1) AU689797B2 (es)
CA (3) CA2402590A1 (es)
DE (5) DE69428122T2 (es)
DK (2) DK0716606T3 (es)
ES (2) ES2260154T3 (es)
HK (2) HK1036753A1 (es)
LU (2) LU90884I2 (es)
NL (2) NL300080I1 (es)
NZ (1) NZ271826A (es)
PT (2) PT716606E (es)
WO (1) WO1995005184A2 (es)

Families Citing this family (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0684958T3 (da) * 1993-02-17 1998-10-19 Btg Int Ltd Polymerer indeholdende guanidinogrupper til anvendelse i terapi
US5487888A (en) 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
GB9503061D0 (en) * 1995-02-16 1995-04-05 British Tech Group Polymeric compounds
DE19528524C2 (de) * 1995-08-03 1999-11-11 Hans Dietl Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung
EP0793960B1 (en) * 1996-03-05 2001-08-01 Mitsubishi Chemical Corporation Use of anion exchange resins for the manufacture of a medicament for the treatment of hyperphosphatemia
CN1230118A (zh) * 1996-07-19 1999-09-29 日研化学株式会社 高磷血症治疗剂
KR20000052744A (ko) * 1996-10-23 2000-08-25 리챠드 지. 워터맨 식이성 인산염 또는 옥살산염의 흡수를 감소시키기 위한 수용성중합체
AU2446497A (en) * 1997-03-25 1998-10-20 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers combined with a calcium supplement for oral administration
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6423754B1 (en) * 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
WO1999040990A1 (en) * 1998-02-17 1999-08-19 University Of Maryland Anion binding polymers and the use thereof
WO1999047587A1 (en) * 1998-03-19 1999-09-23 Geltex Pharmaceuticals, Inc. Continuous crosslinking of polymer gels
US6294163B1 (en) 1998-10-02 2001-09-25 Geltex Pharmaceuticals, Inc. Polymers containing guanidinium groups as bile acid sequestrants
JP4749649B2 (ja) * 1998-10-12 2011-08-17 中外製薬株式会社 リン酸結合性ポリマー
TW568788B (en) 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
WO2000063259A1 (en) * 1999-04-16 2000-10-26 Abbott Laboratories Process for producing cross-linked polyallylamine hydrochloride
US6190649B1 (en) 1999-04-23 2001-02-20 Geltex Pharmaceuticals, Inc. Polyether-based bile acid sequestrants
US6180754B1 (en) 1999-09-03 2001-01-30 The Dow Chemical Company Process for producing cross-linked polyallylamine polymer
US6362266B1 (en) 1999-09-03 2002-03-26 The Dow Chemical Company Process for reducing cohesiveness of polyallylamine polymer gels during drying
WO2001025291A1 (en) * 1999-10-07 2001-04-12 University Of Maryland Sugar binding polymers and the use thereof
EP1223985B1 (en) * 1999-10-15 2005-11-30 Dow Global Technologies Inc. Dialysis solution including polyglycol osmotic agent
US20030202958A1 (en) * 1999-10-15 2003-10-30 Strickland Alan D. Dialysis solution including polyglycol osmotic agent
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
EP1239837B1 (en) * 1999-10-19 2005-01-05 Genzyme Corporation Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
WO2001066606A1 (fr) * 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci
WO2001066607A1 (fr) * 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant
EP1283046A1 (en) 2000-03-13 2003-02-12 Hisamitsu Pharmaceutical Co., Inc. Preventives and/or remedies for hyperphosphatemia
WO2002032974A2 (en) * 2000-10-18 2002-04-25 Fujisawa Pharmaceutical Co., Ltd. Polymer and its use for the treatment and/or prevention of hyperphosphoremia
AU2001292368A1 (en) * 2000-11-28 2002-06-11 Mitsubishi Pharma Corporation Antiobestic agents and health foods
CN1273144C (zh) * 2000-11-28 2006-09-06 三菱制药株式会社 蓄积性含氯化合物的排泄促进剂
AT409630B (de) * 2000-12-13 2002-09-25 Dsm Fine Chem Austria Gmbh Alkylierung von n-bzw. amino- oder ammoniumgruppen haltigen, vernetzten polymeren
DE10065710A1 (de) * 2000-12-29 2002-07-04 Bayer Ag Arzneimittel enthaltend ein Polyamin als Wirksubstanz
US6710162B2 (en) 2001-02-16 2004-03-23 Genzyme Corporation Method of drying a material having a cohesive phase
PT1923064T (pt) * 2001-04-18 2017-08-23 Genzyme Corp Utilização de um aminopolímero para reduzir a glicose sérica
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
EP1379258B1 (en) * 2001-04-18 2006-06-28 Genzyme Corporation Low salt forms of polyallylamine
MXPA03009562A (es) 2001-04-18 2004-02-12 Genzyme Corp METODO PARA TRATAR EL SiNDROME X CON POLIAMINAS ALIFATICAS.
EP1923064B1 (en) 2001-04-18 2017-06-28 Genzyme Corporation Use of amine polymer for lowering serum glucose
MX2008011686A (es) * 2001-05-25 2010-05-27 Marathon Oil Co Inhibicion de sulfuracion del deposito utilizando una inyeccion de agua tratada.
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
JP2003033651A (ja) * 2001-07-24 2003-02-04 Chisso Corp 経口リン吸着剤及びそれを含む食品
US7879869B2 (en) 2001-07-30 2011-02-01 Mitsubishi Tanabe Pharma Corporation Drugs for ameliorating postcibal hyperglycemia
US6600011B2 (en) 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
FR2833169B1 (fr) * 2001-12-07 2004-07-16 Oreal Composition filtrante contenant un derive de 1,3,5-triazine, un derive du dibenzoylmethane, et un derive de 2-hydroxybenzophenone aminosubstitue
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
EP1485391B1 (en) * 2002-03-19 2006-08-23 Genzyme Corporation Phosphate transport inhibitors
AT411463B (de) 2002-09-03 2004-01-26 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von alkylierten n- bzw. amino-, ammonium- oder spirobicyclischen ammoniumgruppen haltigen, vernetzten polymeren
AU2003282867A1 (en) * 2002-10-22 2004-05-13 Genzyme Corporation Amine polymers for promoting bone formation
AT412473B (de) 2003-01-15 2005-03-25 Dsm Fine Chem Austria Gmbh Verfahren zur kontinuierlichen trocknung von n- bzw. amino-, ammonium- oder spirobicyclische ammoniumgruppen haltigen polymeren
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
WO2005082977A1 (en) * 2004-02-23 2005-09-09 E.I. Dupont De Nemours And Company Crosslinked polymers containing biomass derived materials
WO2005082978A1 (en) * 2004-02-23 2005-09-09 E.I. Dupont De Nemours And Company Preparation of crosslinked polymers containing biomass derived materials
EP2335709A1 (en) 2004-03-26 2011-06-22 Mitsubishi Tanabe Pharma Corporation Insulin resistance improving agent
PL3219312T3 (pl) 2004-03-30 2019-07-31 Relypsa, Inc. Polimery wiążące jon i ich zastosowania
US20050276781A1 (en) * 2004-06-09 2005-12-15 Ross Edward A Molecularly imprinted phosphate binders for therapeutic use
CA2579612A1 (en) * 2004-09-24 2006-04-06 Biosphere Medical, Inc. Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof
EP1831266B1 (en) * 2004-10-13 2010-04-07 Ilypsa, Inc. Crosslinked amine polymers
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP4547620B2 (ja) * 2004-12-02 2010-09-22 日東紡績株式会社 架橋アリルアミン類重合体の製造方法
ITME20040015A1 (it) * 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
JP2008526771A (ja) * 2004-12-30 2008-07-24 ジェンザイム コーポレーション 高リン酸血症のための亜鉛含有処置
CN101163731A (zh) * 2005-02-23 2008-04-16 纳幕尔杜邦公司 使用α，ω-二官能醛糖二酰胺作为单体和交联剂的方法
JP2008533272A (ja) * 2005-03-16 2008-08-21 ユーエスヴィー リミテッド 架橋ポリアリルアミンポリマーの調製のための改良された方法
US8492432B2 (en) * 2005-08-17 2013-07-23 Hill's Pet Nutrition, Inc. Methods for the treatment of kidney disease
US8986669B2 (en) * 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
EP3000460A1 (en) * 2005-09-15 2016-03-30 Genzyme Corporation Sachet formulation for amine polymers
AU2012205214B2 (en) * 2005-09-15 2015-05-21 Genzyme Corporation Formulation for Amine Polymers
GB2446076B (en) 2005-09-30 2010-11-24 Ilypsa Inc Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
BRPI0616604A2 (pt) 2005-09-30 2012-12-25 Ilypsa Inc mÉtodo para remover e composiÇço para seletivamente remover Íon de potÁssio do trato gastrintestinal de um mamÍfero, mÉtodo para seletivamente remover Íon de potÁssio de um meio-ambiente, composiÇço farmacÊutica, partÍcula de nécleo-envoltàrio, e, usos de uma partÍcula de nécleo-envoltàrio e de uma composiÇço farmacÊutica
JP2009514966A (ja) * 2005-11-08 2009-04-09 ジェンザイム・コーポレーション 高リン血症のためのマグネシウム含有重合体
EP1973587B1 (en) 2005-12-12 2019-02-06 AllAccem, Inc. Methods and systems for preparing antimicrobial films and coatings
ITRM20060204A1 (it) * 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
JP2009536246A (ja) * 2006-05-05 2009-10-08 ゲンズイメ コーポレーション ホスフェート捕捉剤としてのアミン縮合重合体
JP5147695B2 (ja) 2006-06-16 2013-02-20 田辺三菱製薬株式会社 糸球体疾患の予防及び／または治療剤
EP2043627A2 (en) * 2006-07-05 2009-04-08 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
WO2008011047A2 (en) * 2006-07-18 2008-01-24 Genzyme Corporation Amine dendrimers
WO2008018556A1 (en) 2006-08-09 2008-02-14 Mitsubishi Tanabe Pharma Corporation Tablet
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
RU2009111853A (ru) * 2006-09-01 2010-10-10 Юсв Лимитед (In) Способ получения гидрохлорида севеламера и его лекарственной формы
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
EP2076286B1 (en) 2006-10-25 2016-03-09 Wisconsin Alumni Research Foundation Methods of reducing phosphate absorption using an anti-npt2b antibody
US8877198B2 (en) 2006-10-26 2014-11-04 Wisconsin Alumni Research Foundation Methods of reducing phosphate absorption
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
JP2008169758A (ja) * 2007-01-11 2008-07-24 Bosch Corp ターボチャージャ駆動制御方法及びその装置
ES2522908T3 (es) 2007-02-21 2014-11-19 Allaccem, Inc. Composiciones a base de compuestos policíclicos con puente para la inhibición y el alivio de enfermedades
WO2008103368A1 (en) * 2007-02-23 2008-08-28 Genzyme Corporation Amine polymer compositions
EP2131820A1 (en) * 2007-03-08 2009-12-16 Genzyme Corporation Sulfone polymer compositions
US8034833B2 (en) * 2008-03-20 2011-10-11 Biolink Life Sciences, Inc. Phosphorus binder for treatment of renal disease
EP2152277A1 (en) * 2007-04-27 2010-02-17 Genzyme Corporation Amido-amine dendrimer compositions
EP2168992A1 (en) 2007-07-11 2010-03-31 Toray Industries, Inc. Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes
EP2016947A1 (en) * 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
WO2009023544A2 (en) * 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
TWI468167B (zh) 2007-11-16 2015-01-11 威佛（國際）股份有限公司 藥學組成物
US20100316589A1 (en) * 2007-12-14 2010-12-16 Hitesh Bhagat Coated Pharmaceutical Compositions
US8389640B2 (en) * 2008-04-15 2013-03-05 Lupin Limited Process for the preparation of cross-linked polyallylamine polymer
WO2009154747A1 (en) * 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US8404784B2 (en) * 2008-12-03 2013-03-26 Navinta Llc Manufacturing process of making polymeric amine salts
US20100166861A1 (en) * 2008-12-29 2010-07-01 Kelly Noel Lynch Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
MX2011007760A (es) * 2009-01-22 2011-08-17 Usv Ltd Composiciones farmaceuticas que comprenden polimero vinculante a fosfato.
CA2765370A1 (en) 2009-06-16 2010-12-23 Watson Pharma Private Limited Processes for the preparation of sevelamer carbonate
US8673272B2 (en) * 2009-07-27 2014-03-18 Isp Investments Inc. Ultraviolet-absorbing compounds
GB0921951D0 (en) * 2009-12-16 2010-02-03 Fujifilm Mfg Europe Bv Curable compositions and membranes
JP5377265B2 (ja) * 2009-12-16 2013-12-25 一般財団法人川村理化学研究所 ポリマー／酒石酸結晶性ナノ複合体及びその製造方法
EP2345590B2 (en) 2010-01-15 2016-07-27 Graphic Packaging International, Inc. Flight lug for octagonal cartons
CN105017481B (zh) 2010-02-24 2018-10-02 瑞立普萨公司 用作胆汁酸螯合剂的交联聚乙烯胺、聚烯丙胺和乙烯亚胺
JP5717422B2 (ja) * 2010-11-30 2015-05-13 株式会社パイロットコーポレーション ゲル状組成物の製造方法
IT1404163B1 (it) * 2011-02-01 2013-11-15 Chemi Spa Processo per la preparazione di poliallilamine reticolate o loro sali farmaceuticamente accettabili
ES2563316T3 (es) 2011-02-09 2016-03-14 Synthon Bv Formas estabilizadas de envasado de sevelamer
CN102796262B (zh) * 2011-05-24 2014-11-12 北大方正集团有限公司 一种碳酸司维拉姆的制备方法
EP2773329B1 (en) 2011-11-04 2016-01-13 Synthon BV Pharmaceutical compositions comprising sevelamer
US20130123433A1 (en) 2011-11-14 2013-05-16 Formosa Laboratories, Inc. Method for preparing poly(allylamine) hydrochloride and derivatives therefrom
EP2791183A1 (en) 2011-12-13 2014-10-22 Synthon BV Preparation of sevelamer with reduced content of allylamine
WO2013087237A1 (en) 2011-12-13 2013-06-20 Synthon Bv Purification of sevelamer and related polyallylamines
CN102675510B (zh) * 2012-05-28 2014-04-02 诚达药业股份有限公司 司维拉姆的合成工艺
ES2471340B1 (es) 2012-12-21 2015-08-17 Laboratorios Rubió, S.A. Composición farmacéutica oral para fármacos de elevada posología
EP2968165B1 (en) 2013-03-13 2023-09-13 Biosphere Medical, Inc. Compositions and associated methods for radioisotope-binding microparticles
CN103446179B (zh) * 2013-05-14 2017-03-15 厦门绿洲安源投资管理有限公司 作为磷酸盐、脂肪酸和胆汁酸绑定螯合剂的双亲聚富勒烯树状交联聚阳离子凝胶的应用
LT3003327T (lt) 2013-06-05 2017-12-27 Tricida Inc. Protonus surišantys polimerai, skirti geriamajam vartojimui
CA3205149A1 (en) 2014-12-10 2016-06-16 Tricida, Inc. Proton-binding polymers for oral administration
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
EP3270933B1 (en) 2015-03-20 2020-08-19 Howard University Polysaccharide-polyamine copolymers for removal of phosphate
CN107530370B (zh) 2015-03-20 2021-01-26 杨达志 用于培养哺乳动物细胞的微载体、基质和支架及其制造方法
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration
WO2017153986A1 (en) 2016-03-08 2017-09-14 Technion Research & Development Foundation Limited Disinfection and removal of nitrogen species from saline aquaculture systems
IL262660B2 (en) 2016-05-06 2024-04-01 Tricida Inc Preparations for and method of treating acid-base disorders
WO2018124264A1 (ja) 2016-12-28 2018-07-05 富士フイルム株式会社 窒素原子含有ポリマー又はその塩の乳化液、その製造方法、及び粒子の製造方法
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
WO2019078197A1 (ja) * 2017-10-16 2019-04-25 富士フイルム株式会社 高リン血症治療剤
CA3079171C (en) * 2017-10-16 2023-09-12 Fujifilm Corporation Therapeutic agent for hyperphosphatemia and particles
US10479865B2 (en) 2017-11-01 2019-11-19 Strides Shasun Limited Process for the preparation of sevelamer carbonate
WO2019090176A1 (en) * 2017-11-03 2019-05-09 Tricida, Inc. Compositions for and method of treating acid-base disorders
CN112047854B (zh) * 2020-10-20 2021-07-02 中国科学院长春应用化学研究所 一种n-乙烯基烷基酰胺的制备方法
EP4295836A1 (en) 2022-06-22 2023-12-27 Labomed Pharmaceutical Company S.A. Sachet comprising a liquid suspension of a sevelamer salt
WO2024084076A1 (en) * 2022-10-20 2024-04-25 Universiteit Gent Method to prepare amidated polymers

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE580490A (fr) * 1958-07-15 1960-01-08 Merck & Co Inc Compositions et procédés pour abaisser la teneur en cholestérol du sang
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3332841A (en) * 1961-10-04 1967-07-25 Lilly Co Eli Method of treating hyperacidity
DE1927336A1 (de) * 1968-06-17 1969-12-18 Upjohn Co Orale Dosierungsform zur Bekaempfung von Hypercholesterinaemie
US3980770A (en) * 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
CH604722A5 (es) * 1973-02-09 1978-09-15 Sandoz Ag
US4205064A (en) * 1973-06-11 1980-05-27 Merck & Co., Inc. Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides]
AR206115A1 (es) * 1973-06-11 1976-06-30 Merck & Co Inc Procedimiento para preparar un polimero lineal no ramificado y no reticulado
US4016209A (en) * 1975-04-23 1977-04-05 Merck & Co., Inc. 3-[N'-(3-Halopropyl)-N-'-methylamino]-N,N,N-trimethyl-1-propanaminium halide and acid addition salts thereof
US4181718A (en) * 1975-12-29 1980-01-01 Mason Norbert S Polyanion-stabilized aluminum hydrogels
US4071478A (en) * 1976-06-07 1978-01-31 Merck & Co., Inc. Controlled partially cross-linked 3,3-ionenes
DE2741323A1 (de) * 1977-03-10 1978-09-14 Werner Klaus Konzack Raederfahrzeug
US4143130A (en) * 1977-08-29 1979-03-06 Warren-Teed Laboratories, Inc. Method for treating kidney stones
JPS5566513A (en) * 1978-11-14 1980-05-20 Ono Pharmaceut Co Ltd Drug for arteriosclerosis comprising high polymer compound as active constituent
US4247393A (en) * 1979-01-11 1981-01-27 Wallace Richard A Hemodialysis assist device
GB2090605B (en) * 1980-12-12 1984-09-05 Smith & Nephew Ass Polymer of diallyl ammonium monomers pharmaceutical compositions thereof
JPS6090243A (ja) * 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
EP0162388B1 (en) * 1984-05-11 1989-09-13 Bristol-Myers Company Novel bile sequestrant resin and uses
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
JPS62132830A (ja) * 1985-12-05 1987-06-16 Teijin Ltd 徐放性医薬品組成物
EP0350714B1 (en) * 1988-07-13 1994-03-09 Collaborative Biomedical Products Inc. Tissue immobilization and cell culturing system and method for affixing biologically active moieties to a substrate
KR900701285A (ko) * 1988-08-26 1990-12-01 로버어트 에이 아미테이지 미세-구슬상 콜레스티폴 염산염
GB8829835D0 (en) * 1988-12-21 1989-02-15 Smith Kline French Lab Compounds
DE3901527A1 (de) * 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
JPH0687974B2 (ja) * 1990-03-27 1994-11-09 忠一 平山 発熱物質の吸着材料
JPH0424180A (ja) * 1990-05-16 1992-01-28 Daikin Ind Ltd クローラ式小型運搬機
AU659106B2 (en) * 1990-11-06 1995-05-11 Fgn, Inc. Method for treating colonic polyps by the use of esters and amides of substituted phenyl and pyridyl amino carboxylates
IE914179A1 (en) * 1990-12-07 1992-06-17 Ici Plc Nitrogen derivatives
JP2785529B2 (ja) * 1991-08-21 1998-08-13 日東紡績株式会社 エタノール徐放剤およびそれを用いた食品保存用組成物
EP0534304A1 (de) * 1991-09-21 1993-03-31 Hoechst Aktiengesellschaft Cycloalkylierte Polyethyleniminderivate und ihre Verwendung als Hypolipidämika
SE470006B (sv) * 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
AU3592693A (en) * 1992-01-21 1993-08-03 University Of Utah, The Method and composition for heparin binding using polyaminocations covalently immobilised on polymeric surfaces with polyethylene oxide spacers
WO1993022380A1 (en) * 1992-05-06 1993-11-11 Isp Investments Inc. Polymers of vinyl-pyrrolidone and aminoalkyl acrylamides
DE4227019A1 (de) * 1992-08-14 1994-02-17 Geckeler Kurt E Priv Doz Dr Herstellung und Modifikation von Materialien auf der Basis von Amino- oder Amidpolymeren
US5633344A (en) * 1992-08-20 1997-05-27 E. I. Du Pont De Nemours & Company Crosslinked polymeric ammonium salts
US5302531A (en) * 1992-10-22 1994-04-12 Miles Inc. Composition for the semiquantitative determination of specific gravity of a test sample
DK0684958T3 (da) * 1993-02-17 1998-10-19 Btg Int Ltd Polymerer indeholdende guanidinogrupper til anvendelse i terapi
EP0706399A4 (en) * 1993-06-02 1998-08-12 Geltex Pharma Inc PREPARATIONS AND METHOD FOR REMOVING BILE SALTS

Also Published As

Publication number Publication date
EP1133989A3 (en) 2004-05-12
AU7560794A (en) 1995-03-14
ES2161780T3 (es) 2001-12-16
AU689797B2 (en) 1998-04-09
CA2169356C (en) 2000-07-04
KR960703607A (ko) 1996-08-31
DK0716606T3 (da) 2001-12-17
KR100346766B1 (ko) 2003-10-04
NZ271826A (en) 2000-06-23
DE69434726T2 (de) 2007-01-18
HK1036753A1 (en) 2002-01-18
EP0716606B1 (en) 2001-08-29
JP3113283B2 (ja) 2000-11-27
NL300428I1 (nl) 2010-02-01
EP1133989A2 (en) 2001-09-19
DE69428122T2 (de) 2002-04-18
ATE204756T1 (de) 2001-09-15
PT716606E (pt) 2002-02-28
DE10299003I1 (de) 2002-05-08
JPH09504782A (ja) 1997-05-13
PT1133989E (pt) 2006-08-31
CA2310960A1 (en) 1995-02-23
LU91629I2 (fr) 2011-08-25
DE69434726D1 (de) 2006-06-08
NL300080I1 (nl) 2002-04-02
EP1676581A2 (en) 2006-07-05
CA2169356A1 (en) 1995-02-23
WO1995005184A3 (en) 1995-03-23
DE10299003I2 (de) 2006-07-13
EP1676581A3 (en) 2008-12-03
DE122009000081I1 (de) 2010-04-29
JP2001055336A (ja) 2001-02-27
WO1995005184A2 (en) 1995-02-23
DE69428122D1 (de) 2001-10-04
ES2260154T3 (es) 2006-11-01
CA2402590A1 (en) 1995-02-23
EP1133989B1 (en) 2006-05-03
ATE324900T1 (de) 2006-06-15
DK1133989T3 (da) 2006-09-11
EP0716606A1 (en) 1996-06-19
LU90884I2 (en) 2002-03-25
US5496545A (en) 1996-03-05
CA2310960C (en) 2003-05-27
EP0716606A4 (en) 1999-12-22

Similar Documents

Publication Publication Date Title
HK1009243A1 (en) Phosphate-binding polymers for oral administration
WO1996039156A3 (en) Phosphate-binding polymers for oral administration
EP0699072A4 (en) IRON-BINDING POLYMERS FOR ORAL ADMINISTRATION
BG104727A (en) Pharmaceutical composition of topiramate
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
BG101118A (en) Therapeutical compounds
IL119989A0 (en) Pharmaceutical compositions for oral treatment of multiple sclerosis
CA2163361A1 (en) Therapeutic substituted guanidines
CA2318260A1 (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
CA2330424A1 (en) Improved method for eradication of helicobacter pylori
MY114084A (en) Phosphate - binding polymers for oral administration
MX9705305A (es) Polimeros fijadores de fosfato para administracion oral.
CA2122908A1 (en) Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
CA2239420A1 (en) Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
ES2094093A1 (es) Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
CA2239422A1 (en) Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders
GR920100469A (el) Ανταγωνιστές 5-ΗΤ4 βενζοδιοξανο οξαδιαζόλης.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20140809